TAVR-30
Risk assessment tool
About
This tool helps healthcare professionals identify patients undergoing transcatheter aortic valve replacement who are at higher risk for 30-day readmission. It utilizes data from a large database to provide a simple risk prediction.
What's New in TAVR
2.0
January 24, 2020
Updated graphics and performance improvements
FAQ
What is TAVR-30 used for?
TAVR-30 is a risk assessment tool designed to help identify patients undergoing transcatheter aortic valve replacement (TAVR) who are at a higher risk of 30-day readmission. It aids in planning post-discharge care.
What data does TAVR-30 use for risk assessment?
The tool utilizes data from the Nationwide Readmissions Databases, specifically from January 2013 to September 2015, to predict readmission risk.
Is TAVR-30 a medical advice app?
No, TAVR-30 provides information only and is not a substitute for professional medical advice, diagnosis, or treatment. Users should not rely on it for medical decisions.
What devices does TAVR-30 support?
TAVR-30 is available for iPhone, iPad, and iPod devices, indicating compatibility with Apple's iOS ecosystem.
How frequently is TAVR-30 updated?
The latest version of TAVR-30 is 2.0, which was last updated on January 24, 2020. This suggests updates may not be very frequent.
What is the age rating for TAVR-30?
TAVR-30 has an age rating of 12+, making it suitable for users aged 12 and above.
Does TAVR-30 have ads?
No, TAVR-30 does not contain advertisements. The app is free to use without any ad interruptions.
What is the user feedback on TAVR-30?
TAVR-30 has received a perfect rating of 5.0 stars from 2 ratings, indicating positive user sentiment among its current users.
